ArticleCancers2025
Diagnostic Biomarker Candidates Proposed Using Targeted Lipid Metabolomics Analysis of the Plasma of Patients with PDAC.
Sung-Sik Han, Sang Myung Woo, Jun Hwa Lee, Joon Hee Kang, Sang-Jae Park, Woo Jin Lee, Hyeong Min Park, Jung Won Chun, Su Jung Kim, Hyun Ju Yoo and 2 more
Abstract read
In one paragraphArticle in Cancers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
12 authors.
Sung-Sik HanCenter for Liver and Pancreatobiliary Cancer, National Cancer Center, Goyang 10408, Republic of Korea.
Sang Myung WooCenter for Liver and Pancreatobiliary Cancer, National Cancer Center, Goyang 10408, Republic of Korea.ORCID 0000-0003-3786-4403 Jun Hwa LeeResearch Institute, National Cancer Center, Goyang 10408, Republic of Korea.
Joon Hee KangDepartment of Cancer Biomedical Science, National Cancer Center Graduate School of Cancer Science and Policy, Goyang 10408, Republic of Korea.
Sang-Jae ParkCenter for Liver and Pancreatobiliary Cancer, National Cancer Center, Goyang 10408, Republic of Korea.
Woo Jin LeeCenter for Liver and Pancreatobiliary Cancer, National Cancer Center, Goyang 10408, Republic of Korea.ORCID 0000-0003-2115-6701 Hyeong Min ParkCenter for Liver and Pancreatobiliary Cancer, National Cancer Center, Goyang 10408, Republic of Korea.
Jung Won ChunCenter for Liver and Pancreatobiliary Cancer, National Cancer Center, Goyang 10408, Republic of Korea.ORCID 0000-0003-1964-7501 Su Jung KimDepartment of Convergence Medicine, Department of Digital Medicine, Asan Institute for Life Sciences, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, Republic of Korea.
Hyun Ju YooDepartment of Convergence Medicine, Department of Digital Medicine, Asan Institute for Life Sciences, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, Republic of Korea.ORCID 0000-0003-2617-444X Kyung-Hee KimProteomics Core Facility, Research Core Center, Research Institute, National Cancer Center, Goyang 10408, Republic of Korea.
Funding
National Cancer Center NCC 2210670 and 2510630National Research Foundation of Korea 2017R1A2B2003428
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
CA19-9diagnostic biomarkerlipid metabolomicspancreatic cancer
Identifiers
PMID41008832
PMCPMC12468859
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390